Fixed monthly charges could jump 50%
The Public Utilities Commission of Ohio on Thursday agreed to a measure that could increase fixed monthly charges to 1.4 million Ohio natural gas customers by more than 50% over the next five years.
It means that after five years, gas customers might be paying as much as $58 a month simply to have gas service. The charge doesn’t include the cost of gas itself, the price of which also has increased sharply in recent years. The Consumer’s Counsel, the state’s official watchdog, said it signed off on the increase in part because it’s substantially less than the $80 a month in fixed costs Columbia originally requested.
Not only are people living in mansions able to pay more, they say, it would take more and bigger gas lines to serve larger, more spread-out residences.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Just who are these people on SNAP about to see cuts in food stamp help? In Ohio, a lot of workers and families with childrenCuts to SNAP in March will impact hundreds of thousands of Ohio households of all backgrounds, from older Ohioans and married couples to two-worker households and those with disabilities, according to the latest census estimates.
Read more »
Ohio reports 8,155 more COVID-19 cases: weekly coronavirus update for Thursday, Jan. 26The number of new COVID-19 cases in Ohio stayed nearly the same as last week, showing a slight uptick from 7,961 last week to 8,155 this week.
Read more »
Daisy Hill to lose emergency surgery permanently under new proposalHealth trust approves plan to permanently move the service from Daisy Hill Hospital to Craigavon.
Read more »
Saskatoon council approves debt to pay for citywide snow clearThe city will pile on debt to deal with piled-up snow left over from heavy snowstorms that hit in late December. yxe
Read more »
FDA approves Genentech’s bispecific antibody for lymphomaNature Medicine explores the latest translational and clinical research news, with data from an ongoing clinical trial of mosunetuzumab in relapsed or refractory follicular lymphoma.
Read more »